The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data* Article uri icon

Overview

MeSH Major

  • Lymphoma, Mantle-Cell

publication date

  • June 2, 2017

Research

keywords

  • Article

Identity

Digital Object Identifier (DOI)

  • 10.1080/10428194.2017.1323270

Additional Document Info

start page

  • 1

end page

  • 3